December 19, 2024

How Copper Accumulation Impacts the Liver

From early inflammation to advanced fibrosis, researchers detail the liver damage caused by copper overload and the role of treatment.

Conexiant

December 17, 2024

Food Recall Trends: Listeria, Salmonella, and E. coli Risks

Explore key insights from a 2-decade analysis of US food recalls, revealing alarming trends in foodborne illness outbreaks caused by Listeria, Salmonella, and E. coli, and the need for improved food safety measures.

Conexiant

December 12, 2024

FDA Monitoring Ocaliva for Liver Injury

Intercept Pharmaceuticals' Ocaliva drug under FDA scrutiny for potential liver injury in patients without severe scarring.

Reuters

December 11, 2024

Magnesium Deficiency Linked to MAFLD Risk

A recent study found that severe magnesium deficiency raises the odds of metabolic dysfunction-associated fatty liver disease significantly, highlighting the importance of comprehensive measures for evaluating deficiency and its clinical implications.

Conexiant

December 11, 2024

Study Identifies Viable H. pylori in Root Canals of Infected Teeth

New study finds viable Helicobacter pylori in oral cavity root canals of endodontically infected primary teeth in children, potentially posing a risk for reinfection or transmission. Published in Cell Communication and Signaling.

Conexiant

December 11, 2024

Fasting Glucose Rises Despite BMI Trends

A study analyzing trends in cholesterol, triglyceride, and glucose levels reveals concerning increases in fasting glucose levels and slowing improvements in cholesterol and triglyceride levels, underscoring the need for public health interventions.

Conexiant

December 09, 2024

ADA Guidelines Add Tech Focus for Diabetes Care

The 2025 Standards introduce continuous glucose monitoring recommendations for type 2 diabetes patients not on insulin therapy, while new guidance addresses religious fasting, automated insulin delivery in pregnancy, and specific blood glucose targets for hospitalized patients.

Conexiant

December 02, 2024

Do Antiobesity Meds Curb Alcohol Use?

A recent study found that almost half of participants in a telehealth weight management program reduced their alcohol consumption after starting anti-obesity medications, with significant changes observed in those with higher alcohol use or greater obesity severity.

Conexiant

November 26, 2024

Cocoa Compounds Protect Arteries During Stress: Study

A recent study reveals the potential of high-flavanol cocoa in protecting against endothelial dysfunction during periods of stress and high-fat intake. Findings are published in Food & Function.

Conexiant